Plerixafor (AMD3100) in Cancer and Immune Research: Advan...
2025-10-21
Explore how Plerixafor (AMD3100), a potent CXCR4 chemokine receptor antagonist, advances cancer metastasis inhibition, hematopoietic stem cell mobilization, and immune system research. This article uniquely synthesizes mechanistic insights and emerging translational applications for next-generation experimental design.